Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
161,353
archived clinical trials in
Cancer

Safety and Efficacy Study of the Xoft® Axxent® eBx™ IORT System
A Safety and Efficacy Study of Intra-Operative Radiation Therapy (IORT) Using the Xoft® Axxent® eBx™ System at the Time of Breast Conservation Surgery for Early Stage Breast Cancer
Status: Enrolling
Updated:  12/31/1969
Diablo Valley Oncology and Hematology Medical Group
mi
from
Pleasant Hill, CA
Safety and Efficacy Study of the Xoft® Axxent® eBx™ IORT System
A Safety and Efficacy Study of Intra-Operative Radiation Therapy (IORT) Using the Xoft® Axxent® eBx™ System at the Time of Breast Conservation Surgery for Early Stage Breast Cancer
Status: Enrolling
Updated: 12/31/1969
Diablo Valley Oncology and Hematology Medical Group
mi
from
Pleasant Hill, CA
Click here to add this to my saved trials
Safety and Efficacy Study of the Xoft® Axxent® eBx™ IORT System
A Safety and Efficacy Study of Intra-Operative Radiation Therapy (IORT) Using the Xoft® Axxent® eBx™ System at the Time of Breast Conservation Surgery for Early Stage Breast Cancer
Status: Enrolling
Updated:  12/31/1969
Western Surgical Care, PC
mi
from
Denver, CO
Safety and Efficacy Study of the Xoft® Axxent® eBx™ IORT System
A Safety and Efficacy Study of Intra-Operative Radiation Therapy (IORT) Using the Xoft® Axxent® eBx™ System at the Time of Breast Conservation Surgery for Early Stage Breast Cancer
Status: Enrolling
Updated: 12/31/1969
Western Surgical Care, PC
mi
from
Denver, CO
Click here to add this to my saved trials
Safety and Efficacy Study of the Xoft® Axxent® eBx™ IORT System
A Safety and Efficacy Study of Intra-Operative Radiation Therapy (IORT) Using the Xoft® Axxent® eBx™ System at the Time of Breast Conservation Surgery for Early Stage Breast Cancer
Status: Enrolling
Updated:  12/31/1969
Swedish Medical Center
mi
from
Englewood, CO
Safety and Efficacy Study of the Xoft® Axxent® eBx™ IORT System
A Safety and Efficacy Study of Intra-Operative Radiation Therapy (IORT) Using the Xoft® Axxent® eBx™ System at the Time of Breast Conservation Surgery for Early Stage Breast Cancer
Status: Enrolling
Updated: 12/31/1969
Swedish Medical Center
mi
from
Englewood, CO
Click here to add this to my saved trials
Safety and Efficacy Study of the Xoft® Axxent® eBx™ IORT System
A Safety and Efficacy Study of Intra-Operative Radiation Therapy (IORT) Using the Xoft® Axxent® eBx™ System at the Time of Breast Conservation Surgery for Early Stage Breast Cancer
Status: Enrolling
Updated:  12/31/1969
Florida Hospital Celebration Health
mi
from
Celebration, FL
Safety and Efficacy Study of the Xoft® Axxent® eBx™ IORT System
A Safety and Efficacy Study of Intra-Operative Radiation Therapy (IORT) Using the Xoft® Axxent® eBx™ System at the Time of Breast Conservation Surgery for Early Stage Breast Cancer
Status: Enrolling
Updated: 12/31/1969
Florida Hospital Celebration Health
mi
from
Celebration, FL
Click here to add this to my saved trials
Safety and Efficacy Study of the Xoft® Axxent® eBx™ IORT System
A Safety and Efficacy Study of Intra-Operative Radiation Therapy (IORT) Using the Xoft® Axxent® eBx™ System at the Time of Breast Conservation Surgery for Early Stage Breast Cancer
Status: Enrolling
Updated:  12/31/1969
Doctors Hospital
mi
from
Coral Gables, FL
Safety and Efficacy Study of the Xoft® Axxent® eBx™ IORT System
A Safety and Efficacy Study of Intra-Operative Radiation Therapy (IORT) Using the Xoft® Axxent® eBx™ System at the Time of Breast Conservation Surgery for Early Stage Breast Cancer
Status: Enrolling
Updated: 12/31/1969
Doctors Hospital
mi
from
Coral Gables, FL
Click here to add this to my saved trials
Safety and Efficacy Study of the Xoft® Axxent® eBx™ IORT System
A Safety and Efficacy Study of Intra-Operative Radiation Therapy (IORT) Using the Xoft® Axxent® eBx™ System at the Time of Breast Conservation Surgery for Early Stage Breast Cancer
Status: Enrolling
Updated:  12/31/1969
Martin Health System Center for Clinical Research
mi
from
Stuart, FL
Safety and Efficacy Study of the Xoft® Axxent® eBx™ IORT System
A Safety and Efficacy Study of Intra-Operative Radiation Therapy (IORT) Using the Xoft® Axxent® eBx™ System at the Time of Breast Conservation Surgery for Early Stage Breast Cancer
Status: Enrolling
Updated: 12/31/1969
Martin Health System Center for Clinical Research
mi
from
Stuart, FL
Click here to add this to my saved trials
Safety and Efficacy Study of the Xoft® Axxent® eBx™ IORT System
A Safety and Efficacy Study of Intra-Operative Radiation Therapy (IORT) Using the Xoft® Axxent® eBx™ System at the Time of Breast Conservation Surgery for Early Stage Breast Cancer
Status: Enrolling
Updated:  12/31/1969
Rush University
mi
from
Chicago, IL
Safety and Efficacy Study of the Xoft® Axxent® eBx™ IORT System
A Safety and Efficacy Study of Intra-Operative Radiation Therapy (IORT) Using the Xoft® Axxent® eBx™ System at the Time of Breast Conservation Surgery for Early Stage Breast Cancer
Status: Enrolling
Updated: 12/31/1969
Rush University
mi
from
Chicago, IL
Click here to add this to my saved trials
Safety and Efficacy Study of the Xoft® Axxent® eBx™ IORT System
A Safety and Efficacy Study of Intra-Operative Radiation Therapy (IORT) Using the Xoft® Axxent® eBx™ System at the Time of Breast Conservation Surgery for Early Stage Breast Cancer
Status: Enrolling
Updated:  12/31/1969
Greater Baltimore Medical Center
mi
from
Baltimore, MD
Safety and Efficacy Study of the Xoft® Axxent® eBx™ IORT System
A Safety and Efficacy Study of Intra-Operative Radiation Therapy (IORT) Using the Xoft® Axxent® eBx™ System at the Time of Breast Conservation Surgery for Early Stage Breast Cancer
Status: Enrolling
Updated: 12/31/1969
Greater Baltimore Medical Center
mi
from
Baltimore, MD
Click here to add this to my saved trials
Safety and Efficacy Study of the Xoft® Axxent® eBx™ IORT System
A Safety and Efficacy Study of Intra-Operative Radiation Therapy (IORT) Using the Xoft® Axxent® eBx™ System at the Time of Breast Conservation Surgery for Early Stage Breast Cancer
Status: Enrolling
Updated:  12/31/1969
MedStar Oncology Network - Franklin Square
mi
from
Baltimore, MD
Safety and Efficacy Study of the Xoft® Axxent® eBx™ IORT System
A Safety and Efficacy Study of Intra-Operative Radiation Therapy (IORT) Using the Xoft® Axxent® eBx™ System at the Time of Breast Conservation Surgery for Early Stage Breast Cancer
Status: Enrolling
Updated: 12/31/1969
MedStar Oncology Network - Franklin Square
mi
from
Baltimore, MD
Click here to add this to my saved trials
Safety and Efficacy Study of the Xoft® Axxent® eBx™ IORT System
A Safety and Efficacy Study of Intra-Operative Radiation Therapy (IORT) Using the Xoft® Axxent® eBx™ System at the Time of Breast Conservation Surgery for Early Stage Breast Cancer
Status: Enrolling
Updated:  12/31/1969
Exeter Hospital
mi
from
Exeter, NH
Safety and Efficacy Study of the Xoft® Axxent® eBx™ IORT System
A Safety and Efficacy Study of Intra-Operative Radiation Therapy (IORT) Using the Xoft® Axxent® eBx™ System at the Time of Breast Conservation Surgery for Early Stage Breast Cancer
Status: Enrolling
Updated: 12/31/1969
Exeter Hospital
mi
from
Exeter, NH
Click here to add this to my saved trials
Safety and Efficacy Study of the Xoft® Axxent® eBx™ IORT System
A Safety and Efficacy Study of Intra-Operative Radiation Therapy (IORT) Using the Xoft® Axxent® eBx™ System at the Time of Breast Conservation Surgery for Early Stage Breast Cancer
Status: Enrolling
Updated:  12/31/1969
Staten Island University Hospital
mi
from
Staten Island, NY
Safety and Efficacy Study of the Xoft® Axxent® eBx™ IORT System
A Safety and Efficacy Study of Intra-Operative Radiation Therapy (IORT) Using the Xoft® Axxent® eBx™ System at the Time of Breast Conservation Surgery for Early Stage Breast Cancer
Status: Enrolling
Updated: 12/31/1969
Staten Island University Hospital
mi
from
Staten Island, NY
Click here to add this to my saved trials
Safety and Efficacy Study of the Xoft® Axxent® eBx™ IORT System
A Safety and Efficacy Study of Intra-Operative Radiation Therapy (IORT) Using the Xoft® Axxent® eBx™ System at the Time of Breast Conservation Surgery for Early Stage Breast Cancer
Status: Enrolling
Updated:  12/31/1969
University of Oklahoma
mi
from
Oklahoma City, OK
Safety and Efficacy Study of the Xoft® Axxent® eBx™ IORT System
A Safety and Efficacy Study of Intra-Operative Radiation Therapy (IORT) Using the Xoft® Axxent® eBx™ System at the Time of Breast Conservation Surgery for Early Stage Breast Cancer
Status: Enrolling
Updated: 12/31/1969
University of Oklahoma
mi
from
Oklahoma City, OK
Click here to add this to my saved trials
Safety and Efficacy Study of the Xoft® Axxent® eBx™ IORT System
A Safety and Efficacy Study of Intra-Operative Radiation Therapy (IORT) Using the Xoft® Axxent® eBx™ System at the Time of Breast Conservation Surgery for Early Stage Breast Cancer
Status: Enrolling
Updated:  12/31/1969
Parkridge Medical Center
mi
from
Chattanooga, TN
Safety and Efficacy Study of the Xoft® Axxent® eBx™ IORT System
A Safety and Efficacy Study of Intra-Operative Radiation Therapy (IORT) Using the Xoft® Axxent® eBx™ System at the Time of Breast Conservation Surgery for Early Stage Breast Cancer
Status: Enrolling
Updated: 12/31/1969
Parkridge Medical Center
mi
from
Chattanooga, TN
Click here to add this to my saved trials
Safety and Efficacy Study of the Xoft® Axxent® eBx™ IORT System
A Safety and Efficacy Study of Intra-Operative Radiation Therapy (IORT) Using the Xoft® Axxent® eBx™ System at the Time of Breast Conservation Surgery for Early Stage Breast Cancer
Status: Enrolling
Updated:  12/31/1969
Vanderbilt-Ingram Cancer Center
mi
from
Nashville, TN
Safety and Efficacy Study of the Xoft® Axxent® eBx™ IORT System
A Safety and Efficacy Study of Intra-Operative Radiation Therapy (IORT) Using the Xoft® Axxent® eBx™ System at the Time of Breast Conservation Surgery for Early Stage Breast Cancer
Status: Enrolling
Updated: 12/31/1969
Vanderbilt-Ingram Cancer Center
mi
from
Nashville, TN
Click here to add this to my saved trials
Safety and Efficacy Study of the Xoft® Axxent® eBx™ IORT System
A Safety and Efficacy Study of Intra-Operative Radiation Therapy (IORT) Using the Xoft® Axxent® eBx™ System at the Time of Breast Conservation Surgery for Early Stage Breast Cancer
Status: Enrolling
Updated:  12/31/1969
Sentara Northern Virginia Medical Center
mi
from
Woodbridge, VA
Safety and Efficacy Study of the Xoft® Axxent® eBx™ IORT System
A Safety and Efficacy Study of Intra-Operative Radiation Therapy (IORT) Using the Xoft® Axxent® eBx™ System at the Time of Breast Conservation Surgery for Early Stage Breast Cancer
Status: Enrolling
Updated: 12/31/1969
Sentara Northern Virginia Medical Center
mi
from
Woodbridge, VA
Click here to add this to my saved trials
Safety and Efficacy Study of the Xoft® Axxent® eBx™ IORT System
A Safety and Efficacy Study of Intra-Operative Radiation Therapy (IORT) Using the Xoft® Axxent® eBx™ System at the Time of Breast Conservation Surgery for Early Stage Breast Cancer
Status: Enrolling
Updated:  12/31/1969
Lutheran Hospital of Indiana
mi
from
Fort Wayne, IN
Safety and Efficacy Study of the Xoft® Axxent® eBx™ IORT System
A Safety and Efficacy Study of Intra-Operative Radiation Therapy (IORT) Using the Xoft® Axxent® eBx™ System at the Time of Breast Conservation Surgery for Early Stage Breast Cancer
Status: Enrolling
Updated: 12/31/1969
Lutheran Hospital of Indiana
mi
from
Fort Wayne, IN
Click here to add this to my saved trials
Safety and Efficacy Study of the Xoft® Axxent® eBx™ IORT System
A Safety and Efficacy Study of Intra-Operative Radiation Therapy (IORT) Using the Xoft® Axxent® eBx™ System at the Time of Breast Conservation Surgery for Early Stage Breast Cancer
Status: Enrolling
Updated:  12/31/1969
Tri-City Medical Center
mi
from
Oceanside, CA
Safety and Efficacy Study of the Xoft® Axxent® eBx™ IORT System
A Safety and Efficacy Study of Intra-Operative Radiation Therapy (IORT) Using the Xoft® Axxent® eBx™ System at the Time of Breast Conservation Surgery for Early Stage Breast Cancer
Status: Enrolling
Updated: 12/31/1969
Tri-City Medical Center
mi
from
Oceanside, CA
Click here to add this to my saved trials
Safety and Efficacy Study of the Xoft® Axxent® eBx™ IORT System
A Safety and Efficacy Study of Intra-Operative Radiation Therapy (IORT) Using the Xoft® Axxent® eBx™ System at the Time of Breast Conservation Surgery for Early Stage Breast Cancer
Status: Enrolling
Updated:  12/31/1969
Monash Health / Peter MacCallum Cancer Centre
mi
from
Clayton,
Safety and Efficacy Study of the Xoft® Axxent® eBx™ IORT System
A Safety and Efficacy Study of Intra-Operative Radiation Therapy (IORT) Using the Xoft® Axxent® eBx™ System at the Time of Breast Conservation Surgery for Early Stage Breast Cancer
Status: Enrolling
Updated: 12/31/1969
Monash Health / Peter MacCallum Cancer Centre
mi
from
Clayton,
Click here to add this to my saved trials
Safety and Efficacy Study of the Xoft® Axxent® eBx™ IORT System
A Safety and Efficacy Study of Intra-Operative Radiation Therapy (IORT) Using the Xoft® Axxent® eBx™ System at the Time of Breast Conservation Surgery for Early Stage Breast Cancer
Status: Enrolling
Updated:  12/31/1969
MedStar Oncology Network - Good Samaritan Hospital
mi
from
Baltimore, MD
Safety and Efficacy Study of the Xoft® Axxent® eBx™ IORT System
A Safety and Efficacy Study of Intra-Operative Radiation Therapy (IORT) Using the Xoft® Axxent® eBx™ System at the Time of Breast Conservation Surgery for Early Stage Breast Cancer
Status: Enrolling
Updated: 12/31/1969
MedStar Oncology Network - Good Samaritan Hospital
mi
from
Baltimore, MD
Click here to add this to my saved trials
A Study of IMC-TR1 in Participants With Advanced Solid Tumors
Phase 1 Study of Anti-TGFβRII Monoclonal Antibody IMC-TR1 (LY3022859) in Patients With Advanced Solid Tumors That Have Failed Standard Therapy or for Which No Standard is Available
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
mi
from
Nashville, TN
A Study of IMC-TR1 in Participants With Advanced Solid Tumors
Phase 1 Study of Anti-TGFβRII Monoclonal Antibody IMC-TR1 (LY3022859) in Patients With Advanced Solid Tumors That Have Failed Standard Therapy or for Which No Standard is Available
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
mi
from
Nashville, TN
Click here to add this to my saved trials
A Study of IMC-TR1 in Participants With Advanced Solid Tumors
Phase 1 Study of Anti-TGFβRII Monoclonal Antibody IMC-TR1 (LY3022859) in Patients With Advanced Solid Tumors That Have Failed Standard Therapy or for Which No Standard is Available
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
mi
from
Houston, TX
A Study of IMC-TR1 in Participants With Advanced Solid Tumors
Phase 1 Study of Anti-TGFβRII Monoclonal Antibody IMC-TR1 (LY3022859) in Patients With Advanced Solid Tumors That Have Failed Standard Therapy or for Which No Standard is Available
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
mi
from
Houston, TX
Click here to add this to my saved trials
A Study of IMC-TR1 in Participants With Advanced Solid Tumors
Phase 1 Study of Anti-TGFβRII Monoclonal Antibody IMC-TR1 (LY3022859) in Patients With Advanced Solid Tumors That Have Failed Standard Therapy or for Which No Standard is Available
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
mi
from
San Antonio, TX
A Study of IMC-TR1 in Participants With Advanced Solid Tumors
Phase 1 Study of Anti-TGFβRII Monoclonal Antibody IMC-TR1 (LY3022859) in Patients With Advanced Solid Tumors That Have Failed Standard Therapy or for Which No Standard is Available
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
mi
from
San Antonio, TX
Click here to add this to my saved trials
4D Image-Guided Partial Breast Radiation in Stage 0 and l Breast Cancer
A Pilot Study of Four-Dimensional Conformal Image Guided Accelerated Partial Breast Irradiation In The Treatment Of Stage 0 and l Breast Cancer
Status: Enrolling
Updated:  12/31/1969
Smilow Cancer Hospital Care Center, Yale New Haven Hospital
mi
from
New Haven, CT
4D Image-Guided Partial Breast Radiation in Stage 0 and l Breast Cancer
A Pilot Study of Four-Dimensional Conformal Image Guided Accelerated Partial Breast Irradiation In The Treatment Of Stage 0 and l Breast Cancer
Status: Enrolling
Updated: 12/31/1969
Smilow Cancer Hospital Care Center, Yale New Haven Hospital
mi
from
New Haven, CT
Click here to add this to my saved trials
Young and Strong: An Education and Supportive Care Intervention Study for Young Women With Breast Cancer
Young and Strong: An Education and Supportive Care Intervention Study for Young Women With Breast Cancer
Status: Enrolling
Updated:  12/31/1969
University of Colorado
mi
from
Aurora, CO
Young and Strong: An Education and Supportive Care Intervention Study for Young Women With Breast Cancer
Young and Strong: An Education and Supportive Care Intervention Study for Young Women With Breast Cancer
Status: Enrolling
Updated: 12/31/1969
University of Colorado
mi
from
Aurora, CO
Click here to add this to my saved trials
Young and Strong: An Education and Supportive Care Intervention Study for Young Women With Breast Cancer
Young and Strong: An Education and Supportive Care Intervention Study for Young Women With Breast Cancer
Status: Enrolling
Updated:  12/31/1969
Penrose St. Francis Health Services
mi
from
Colorado Springs, CO
Young and Strong: An Education and Supportive Care Intervention Study for Young Women With Breast Cancer
Young and Strong: An Education and Supportive Care Intervention Study for Young Women With Breast Cancer
Status: Enrolling
Updated: 12/31/1969
Penrose St. Francis Health Services
mi
from
Colorado Springs, CO
Click here to add this to my saved trials
Young and Strong: An Education and Supportive Care Intervention Study for Young Women With Breast Cancer
Young and Strong: An Education and Supportive Care Intervention Study for Young Women With Breast Cancer
Status: Enrolling
Updated:  12/31/1969
Presence Resurrection Medical Center
mi
from
Chicago, IL
Young and Strong: An Education and Supportive Care Intervention Study for Young Women With Breast Cancer
Young and Strong: An Education and Supportive Care Intervention Study for Young Women With Breast Cancer
Status: Enrolling
Updated: 12/31/1969
Presence Resurrection Medical Center
mi
from
Chicago, IL
Click here to add this to my saved trials
Young and Strong: An Education and Supportive Care Intervention Study for Young Women With Breast Cancer
Young and Strong: An Education and Supportive Care Intervention Study for Young Women With Breast Cancer
Status: Enrolling
Updated:  12/31/1969
Albert Einstein Medical Center
mi
from
Philadelphia, PA
Young and Strong: An Education and Supportive Care Intervention Study for Young Women With Breast Cancer
Young and Strong: An Education and Supportive Care Intervention Study for Young Women With Breast Cancer
Status: Enrolling
Updated: 12/31/1969
Albert Einstein Medical Center
mi
from
Philadelphia, PA
Click here to add this to my saved trials
Study of Lung Cancer in Appalachian Kentucky: The Role of Environmental Carcinogens
A Population-based Case-control Study of Lung Cancer in Appalachian Kentucky: The Role of Environmental Carcinogens
Status: Enrolling
Updated:  12/31/1969
University of Kentucky
mi
from
Lexington, KY
Study of Lung Cancer in Appalachian Kentucky: The Role of Environmental Carcinogens
A Population-based Case-control Study of Lung Cancer in Appalachian Kentucky: The Role of Environmental Carcinogens
Status: Enrolling
Updated: 12/31/1969
University of Kentucky
mi
from
Lexington, KY
Click here to add this to my saved trials
Dose-Finding Trial of F-627 in Women With Breast Cancer Receiving Myelotoxic Chemotherapy
A Phase II, Randomized, Multi-Centre, Open-Label, Active-Controlled, Dose-Finding Trial of F-627 in Women With Breast Cancer Receiving Myelotoxic Chemotherapy
Status: Enrolling
Updated:  12/31/1969
Community Hospital Anderson
mi
from
Anderson, IN
Dose-Finding Trial of F-627 in Women With Breast Cancer Receiving Myelotoxic Chemotherapy
A Phase II, Randomized, Multi-Centre, Open-Label, Active-Controlled, Dose-Finding Trial of F-627 in Women With Breast Cancer Receiving Myelotoxic Chemotherapy
Status: Enrolling
Updated: 12/31/1969
Community Hospital Anderson
mi
from
Anderson, IN
Click here to add this to my saved trials
Cabazitaxel and Radiation For Patients With Pathologically Determined Stage 3 Prostate Cancer and/or Patients With PSA Elevation (>0.1- < 2.0 ng/mL)
Cabazitaxel and Radiation For Patients With Pathologically Determined Stage 3 Prostate Cancer and/or Patients With PSA Elevation (>0.1- < 2.0 ng/mL) Following Radical Prostatectomy
Status: Enrolling
Updated:  12/31/1969
Miriam Hospital
mi
from
Providence, RI
Cabazitaxel and Radiation For Patients With Pathologically Determined Stage 3 Prostate Cancer and/or Patients With PSA Elevation (>0.1- < 2.0 ng/mL)
Cabazitaxel and Radiation For Patients With Pathologically Determined Stage 3 Prostate Cancer and/or Patients With PSA Elevation (>0.1- < 2.0 ng/mL) Following Radical Prostatectomy
Status: Enrolling
Updated: 12/31/1969
Miriam Hospital
mi
from
Providence, RI
Click here to add this to my saved trials
Low Dose Naltrexone for Metastatic Melanoma, Castrate Resistant Prostate Cancer and Renal Cancer
Low Dose Naltrexone for Metastatic Melanoma, Castrate Resistant Prostate Cancer and Renal Cancer: A Phase II Brown University Oncology Group Research Project
Status: Enrolling
Updated:  12/31/1969
Miriam Hospital
mi
from
Providence, RI
Low Dose Naltrexone for Metastatic Melanoma, Castrate Resistant Prostate Cancer and Renal Cancer
Low Dose Naltrexone for Metastatic Melanoma, Castrate Resistant Prostate Cancer and Renal Cancer: A Phase II Brown University Oncology Group Research Project
Status: Enrolling
Updated: 12/31/1969
Miriam Hospital
mi
from
Providence, RI
Click here to add this to my saved trials
CRLX101 in Combination With Bevacizumab for Recurrent Ovarian/Tubal/Peritoneal Cancer
A Phase II, 2-stage Trial of CRLX101 in Combination With Bevacizumab in Recurrent Platinum-Resistant Ovarian, Tubal and Peritoneal Cancer
Status: Enrolling
Updated:  12/31/1969
Massachusetts General Hospital
mi
from
Boston, MA
CRLX101 in Combination With Bevacizumab for Recurrent Ovarian/Tubal/Peritoneal Cancer
A Phase II, 2-stage Trial of CRLX101 in Combination With Bevacizumab in Recurrent Platinum-Resistant Ovarian, Tubal and Peritoneal Cancer
Status: Enrolling
Updated: 12/31/1969
Massachusetts General Hospital
mi
from
Boston, MA
Click here to add this to my saved trials
CRLX101 in Combination With Bevacizumab for Recurrent Ovarian/Tubal/Peritoneal Cancer
A Phase II, 2-stage Trial of CRLX101 in Combination With Bevacizumab in Recurrent Platinum-Resistant Ovarian, Tubal and Peritoneal Cancer
Status: Enrolling
Updated:  12/31/1969
Beth Israel Deaconess Medical Center
mi
from
Boston, MA
CRLX101 in Combination With Bevacizumab for Recurrent Ovarian/Tubal/Peritoneal Cancer
A Phase II, 2-stage Trial of CRLX101 in Combination With Bevacizumab in Recurrent Platinum-Resistant Ovarian, Tubal and Peritoneal Cancer
Status: Enrolling
Updated: 12/31/1969
Beth Israel Deaconess Medical Center
mi
from
Boston, MA
Click here to add this to my saved trials
CRLX101 in Combination With Bevacizumab for Recurrent Ovarian/Tubal/Peritoneal Cancer
A Phase II, 2-stage Trial of CRLX101 in Combination With Bevacizumab in Recurrent Platinum-Resistant Ovarian, Tubal and Peritoneal Cancer
Status: Enrolling
Updated:  12/31/1969
Brigham and Women's Hosp
mi
from
Boston, MA
CRLX101 in Combination With Bevacizumab for Recurrent Ovarian/Tubal/Peritoneal Cancer
A Phase II, 2-stage Trial of CRLX101 in Combination With Bevacizumab in Recurrent Platinum-Resistant Ovarian, Tubal and Peritoneal Cancer
Status: Enrolling
Updated: 12/31/1969
Brigham and Women's Hosp
mi
from
Boston, MA
Click here to add this to my saved trials
CRLX101 in Combination With Bevacizumab for Recurrent Ovarian/Tubal/Peritoneal Cancer
A Phase II, 2-stage Trial of CRLX101 in Combination With Bevacizumab in Recurrent Platinum-Resistant Ovarian, Tubal and Peritoneal Cancer
Status: Enrolling
Updated:  12/31/1969
Dana-Farber Cancer Institute
mi
from
Boston, MA
CRLX101 in Combination With Bevacizumab for Recurrent Ovarian/Tubal/Peritoneal Cancer
A Phase II, 2-stage Trial of CRLX101 in Combination With Bevacizumab in Recurrent Platinum-Resistant Ovarian, Tubal and Peritoneal Cancer
Status: Enrolling
Updated: 12/31/1969
Dana-Farber Cancer Institute
mi
from
Boston, MA
Click here to add this to my saved trials
Aflibercept and FOLFOX6 Treatment for Previously Untreated Stage IV Colorectal Cancer
A Phase II Study of the Combination of Aflibercept (VEGF-Trap) Plus Modified FOLFOX 6 in Patients With Previously Untreated Metastatic Colorectal Cancer
Status: Enrolling
Updated:  12/31/1969
University of Michigan
mi
from
Ann Arbor, MI
Aflibercept and FOLFOX6 Treatment for Previously Untreated Stage IV Colorectal Cancer
A Phase II Study of the Combination of Aflibercept (VEGF-Trap) Plus Modified FOLFOX 6 in Patients With Previously Untreated Metastatic Colorectal Cancer
Status: Enrolling
Updated: 12/31/1969
University of Michigan
mi
from
Ann Arbor, MI
Click here to add this to my saved trials
Aflibercept and FOLFOX6 Treatment for Previously Untreated Stage IV Colorectal Cancer
A Phase II Study of the Combination of Aflibercept (VEGF-Trap) Plus Modified FOLFOX 6 in Patients With Previously Untreated Metastatic Colorectal Cancer
Status: Enrolling
Updated:  12/31/1969
Montefiore Medical Center
mi
from
Bronx, NY
Aflibercept and FOLFOX6 Treatment for Previously Untreated Stage IV Colorectal Cancer
A Phase II Study of the Combination of Aflibercept (VEGF-Trap) Plus Modified FOLFOX 6 in Patients With Previously Untreated Metastatic Colorectal Cancer
Status: Enrolling
Updated: 12/31/1969
Montefiore Medical Center
mi
from
Bronx, NY
Click here to add this to my saved trials
Aflibercept and FOLFOX6 Treatment for Previously Untreated Stage IV Colorectal Cancer
A Phase II Study of the Combination of Aflibercept (VEGF-Trap) Plus Modified FOLFOX 6 in Patients With Previously Untreated Metastatic Colorectal Cancer
Status: Enrolling
Updated:  12/31/1969
Roswell Park Cancer Institute
mi
from
Buffalo, NY
Aflibercept and FOLFOX6 Treatment for Previously Untreated Stage IV Colorectal Cancer
A Phase II Study of the Combination of Aflibercept (VEGF-Trap) Plus Modified FOLFOX 6 in Patients With Previously Untreated Metastatic Colorectal Cancer
Status: Enrolling
Updated: 12/31/1969
Roswell Park Cancer Institute
mi
from
Buffalo, NY
Click here to add this to my saved trials
Aflibercept and FOLFOX6 Treatment for Previously Untreated Stage IV Colorectal Cancer
A Phase II Study of the Combination of Aflibercept (VEGF-Trap) Plus Modified FOLFOX 6 in Patients With Previously Untreated Metastatic Colorectal Cancer
Status: Enrolling
Updated:  12/31/1969
Univ of North Carolina
mi
from
Chapel Hill, NC
Aflibercept and FOLFOX6 Treatment for Previously Untreated Stage IV Colorectal Cancer
A Phase II Study of the Combination of Aflibercept (VEGF-Trap) Plus Modified FOLFOX 6 in Patients With Previously Untreated Metastatic Colorectal Cancer
Status: Enrolling
Updated: 12/31/1969
Univ of North Carolina
mi
from
Chapel Hill, NC
Click here to add this to my saved trials
Aflibercept and FOLFOX6 Treatment for Previously Untreated Stage IV Colorectal Cancer
A Phase II Study of the Combination of Aflibercept (VEGF-Trap) Plus Modified FOLFOX 6 in Patients With Previously Untreated Metastatic Colorectal Cancer
Status: Enrolling
Updated:  12/31/1969
Ohio State University Medical Center
mi
from
Columbus, OH
Aflibercept and FOLFOX6 Treatment for Previously Untreated Stage IV Colorectal Cancer
A Phase II Study of the Combination of Aflibercept (VEGF-Trap) Plus Modified FOLFOX 6 in Patients With Previously Untreated Metastatic Colorectal Cancer
Status: Enrolling
Updated: 12/31/1969
Ohio State University Medical Center
mi
from
Columbus, OH
Click here to add this to my saved trials
Aflibercept and FOLFOX6 Treatment for Previously Untreated Stage IV Colorectal Cancer
A Phase II Study of the Combination of Aflibercept (VEGF-Trap) Plus Modified FOLFOX 6 in Patients With Previously Untreated Metastatic Colorectal Cancer
Status: Enrolling
Updated:  12/31/1969
Virginia Commonwealth University
mi
from
Richmond, VA
Aflibercept and FOLFOX6 Treatment for Previously Untreated Stage IV Colorectal Cancer
A Phase II Study of the Combination of Aflibercept (VEGF-Trap) Plus Modified FOLFOX 6 in Patients With Previously Untreated Metastatic Colorectal Cancer
Status: Enrolling
Updated: 12/31/1969
Virginia Commonwealth University
mi
from
Richmond, VA
Click here to add this to my saved trials
Analgesic Effects of Topical Ketamine Mouthwash in Patients Receiving Chemoradiation or Radiotherapy for Head & Neck Cancer
Analgesic Effects of Topical Ketamine Mouthwash in Patients Receiving Chemoradiation or Radiotherapy for Head and Neck Cancer
Status: Enrolling
Updated:  12/31/1969
Dartmouth Hitchcock Medical Center
mi
from
Lebanon, NH
Analgesic Effects of Topical Ketamine Mouthwash in Patients Receiving Chemoradiation or Radiotherapy for Head & Neck Cancer
Analgesic Effects of Topical Ketamine Mouthwash in Patients Receiving Chemoradiation or Radiotherapy for Head and Neck Cancer
Status: Enrolling
Updated: 12/31/1969
Dartmouth Hitchcock Medical Center
mi
from
Lebanon, NH
Click here to add this to my saved trials
Conformal High Dose Intensity Modulated Radiation Therapy for Disease to Thoracic and Lumbar Spine
Conformal High Dose Intensity Modulated Radiation Therapy for Asymptomatic Metastatic Disease to the Thoracic and Lumbar Spine
Status: Enrolling
Updated:  12/31/1969
University of Kentucky
mi
from
Lexington, KY
Conformal High Dose Intensity Modulated Radiation Therapy for Disease to Thoracic and Lumbar Spine
Conformal High Dose Intensity Modulated Radiation Therapy for Asymptomatic Metastatic Disease to the Thoracic and Lumbar Spine
Status: Enrolling
Updated: 12/31/1969
University of Kentucky
mi
from
Lexington, KY
Click here to add this to my saved trials
Positron Emission Tomography (PET) Study for Staging of Muscle Invasive Bladder Cancer
LCCC 1209: Pilot Study of [18F] Fluorodeoxyglucose Positron Emission Tomography-Magnetic Resonance Imaging (FDG-PET-MRI) for Staging of Muscle-Invasive Bladder Cancer
Status: Enrolling
Updated:  12/31/1969
Lineberger Comprehensive Cancer Center
mi
from
Chapel Hill, NC
Positron Emission Tomography (PET) Study for Staging of Muscle Invasive Bladder Cancer
LCCC 1209: Pilot Study of [18F] Fluorodeoxyglucose Positron Emission Tomography-Magnetic Resonance Imaging (FDG-PET-MRI) for Staging of Muscle-Invasive Bladder Cancer
Status: Enrolling
Updated: 12/31/1969
Lineberger Comprehensive Cancer Center
mi
from
Chapel Hill, NC
Click here to add this to my saved trials
High-Dose Rate Brachytherapy and Stereotactic Body Radiation Therapy in Treating Patients With Prostate Cancer
Phase I Trial of High Dose Rate Brachytherapy Combined With Stereotactic Body Radiation Therapy for Intermediate Risk Prostate Cancer Patients
Status: Enrolling
Updated:  12/31/1969
Thomas Jefferson University
mi
from
Philadelphia, PA
High-Dose Rate Brachytherapy and Stereotactic Body Radiation Therapy in Treating Patients With Prostate Cancer
Phase I Trial of High Dose Rate Brachytherapy Combined With Stereotactic Body Radiation Therapy for Intermediate Risk Prostate Cancer Patients
Status: Enrolling
Updated: 12/31/1969
Thomas Jefferson University
mi
from
Philadelphia, PA
Click here to add this to my saved trials
Negative Pressure Therapy in Preventing Infection After Surgery in Patients With Colon, Rectal, Pancreatic, or Peritoneal Surface Cancer
The Effect of Negative Pressure Therapy on Incisional Surgical Site Infections
Status: Enrolling
Updated:  12/31/1969
Comprehensive Cancer Center of Wake Forest University
mi
from
Winston-Salem, NC
Negative Pressure Therapy in Preventing Infection After Surgery in Patients With Colon, Rectal, Pancreatic, or Peritoneal Surface Cancer
The Effect of Negative Pressure Therapy on Incisional Surgical Site Infections
Status: Enrolling
Updated: 12/31/1969
Comprehensive Cancer Center of Wake Forest University
mi
from
Winston-Salem, NC
Click here to add this to my saved trials
Stereotactic Body Radiation Therapy in Stage II/III Non Small Cell Lung Cancer
Stereotactic Body Radiation Therapy for Post-chemoradiation Residual Disease in Stage II/III Non-small Cell Lung Cancer
Status: Enrolling
Updated:  12/31/1969
Markey Cancer Center
mi
from
Lexington, KY
Stereotactic Body Radiation Therapy in Stage II/III Non Small Cell Lung Cancer
Stereotactic Body Radiation Therapy for Post-chemoradiation Residual Disease in Stage II/III Non-small Cell Lung Cancer
Status: Enrolling
Updated: 12/31/1969
Markey Cancer Center
mi
from
Lexington, KY
Click here to add this to my saved trials
Collecting Solid Tumor Tissue to Identify New Treatments
Prospective Procurement of Solid Tumor Tissue to Identify Novel Therapeutic Targets
Status: Enrolling
Updated:  12/31/1969
National Institutes of Health Clinical Center, 9000 Rockville Pike
mi
from
Bethesda, MD
Collecting Solid Tumor Tissue to Identify New Treatments
Prospective Procurement of Solid Tumor Tissue to Identify Novel Therapeutic Targets
Status: Enrolling
Updated: 12/31/1969
National Institutes of Health Clinical Center, 9000 Rockville Pike
mi
from
Bethesda, MD
Click here to add this to my saved trials
Gemcitabine Hydrochloride, Dasatinib, and Erlotinib Hydrochloride in Treating Patients With Pancreatic Cancer That Is Metastatic or Cannot Be Removed by Surgery
A Phase 1 Study of Gemcitabine, Dasatinib and Erlotinib in Patients With Advanced Pancreatic Carcinoma
Status: Enrolling
Updated:  12/31/1969
Vanderbilt University/Ingram Cancer Center
mi
from
Nashville, TN
Gemcitabine Hydrochloride, Dasatinib, and Erlotinib Hydrochloride in Treating Patients With Pancreatic Cancer That Is Metastatic or Cannot Be Removed by Surgery
A Phase 1 Study of Gemcitabine, Dasatinib and Erlotinib in Patients With Advanced Pancreatic Carcinoma
Status: Enrolling
Updated: 12/31/1969
Vanderbilt University/Ingram Cancer Center
mi
from
Nashville, TN
Click here to add this to my saved trials
A Study of Neoadjuvant FOLFIRINOX and FDR-Gemcitabine With Concurrent IMRT in Patients
A Phase II Study of Neoadjuvant FOLFIRINOX and FDR-Gemcitabine With Concurrent IMRT in Patients With Borderline Resectable Pancreatic Cancer
Status: Enrolling
Updated:  12/31/1969
University of Michigan Comprehensive Cancer Center
mi
from
Ann Arbor, MI
A Study of Neoadjuvant FOLFIRINOX and FDR-Gemcitabine With Concurrent IMRT in Patients
A Phase II Study of Neoadjuvant FOLFIRINOX and FDR-Gemcitabine With Concurrent IMRT in Patients With Borderline Resectable Pancreatic Cancer
Status: Enrolling
Updated: 12/31/1969
University of Michigan Comprehensive Cancer Center
mi
from
Ann Arbor, MI
Click here to add this to my saved trials